Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9Genitourinary 2Gastrointestinal 2Thoracic 1Plasma cell 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 1214Triple Negative Breast Neoplasms 216Ovarian Neoplasms 109Carcinoma, Non-Small-Cell Lung 85Colorectal Neoplasms 82Neoplasm Metastasis 78Prostatic Neoplasms 75Neoplasms 68Lung Neoplasms 67Melanoma 56Endometrial Neoplasms 49Stomach Neoplasms 48Pancreatic Neoplasms 48Uterine Cervical Neoplasms 42Squamous Cell Carcinoma of Head and Neck 37Colonic Neoplasms 34Carcinoma, Intraductal, Noninfiltrating 33Carcinoma, Renal Cell 32Head and Neck Neoplasms 30Sarcoma 26Esophageal Neoplasms 25Breast Carcinoma In Situ 24Small Cell Lung Carcinoma 23Brain Neoplasms 22Urinary Bladder Neoplasms 21Carcinoma, Transitional Cell 19Advanced Breast Cancer 19Anatomic Stage I Breast Cancer AJCC v8 17Gastrointestinal Neoplasms 16Thyroid Neoplasms 15

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Breast × 90 days × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡